|
|
 Previous Article | Table of Contents | Next Article 
Homozygous deletions of p16/MTS1 gene are frequent but mutations are
infrequent in childhood T-cell acute lymphoblastic leukemia
H Ohnishi, M Kawamura, K Ida, XM Sheng, R Hanada, T Nobori, S Yamamori and Y Hayashi
Department of Pediatrics, Faculty of Medicine, University of Tokyo, Japan.
Fifty-six primary childhood T-cell acute lymphoblastic leukemia (T-ALL)
samples and 17 T-ALL cell lines were examined for mutations and homozygous
deletions of the p16/MTS1 gene using polymerase chain reaction
single-strand conformation polymorphism and Southern blot analysis.
Homozygous deletions were found in 22 primary samples (39%) and in 10 cell
lines (59%). In contrast, mutations including small deletions and/or
insertions were identified in only 4 primary samples (7%) and in 2 cell
lines (12%). Mutations included samples (7%) and in 2 cell lines (12%).
Mutations included one nonsense mutation at codon 72, one missense mutation
at codon 58, one deletion (29 bp from codon 52-61), one insertion (7 bp
into codon 50), and two deletion/insertions (codon 63 and intron 1). Four
of the six mutations caused subsequent stop codon and presumably produced
truncated p16 protein. Our results suggest that p16 gene alterations are
involved in the development of T- ALLs and that the inactivation of the p16
gene occurs mainly through homozygous deletions rather than mutations.
Volume 86,
Issue 4,
pp. 1269-1275,
08/15/1995
Copyright © 1995 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. S. Rao, J. O'Neil, C. D. Liberator, J. S. Hardwick, X. Dai, T. Zhang, E. Tyminski, J. Yuan, N. E. Kohl, V. M. Richon, et al.
Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells
Cancer Res.,
April 1, 2009;
69(7):
3060 - 3068.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sulong, A. V. Moorman, J. A. E. Irving, J. C. Strefford, Z. J. Konn, M. C. Case, L. Minto, K. E. Barber, H. Parker, S. L. Wright, et al.
A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups
Blood,
January 1, 2009;
113(1):
100 - 107.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Mancini, D. Scappaticci, G. Cimino, M. Nanni, V. Derme, L. Elia, A. Tafuri, M. Vignetti, A. Vitale, A. Cuneo, et al.
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol
Blood,
May 1, 2005;
105(9):
3434 - 3441.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Kitagawa, K. Inoue, S. Sasaki, Y. Hayashi, Y. Matsuo, M. R. Lieber, H. Mizoguchi, J. Yokota, and T. Kohno
Prevalent Involvement of Illegitimate V(D)J Recombination in Chromosome 9p21 Deletions in Lymphoid Leukemia
J. Biol. Chem.,
November 22, 2002;
277(48):
46289 - 46297.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Dalle, M. Fournier, B. Nelken, F. Mazingue, J.-L. Lai, F. Bauters, P. Fenaux, and B. Quesnel
p16INK4a immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemia
Blood,
April 1, 2002;
99(7):
2620 - 2623.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.S. Chim, R. Liang, C.Y.Y. Tam, and Y.L. Kwong
Methylation of p15 and p16 Genes in Acute Promyelocytic Leukemia: Potential Diagnostic and Prognostic Significance
J. Clin. Oncol.,
April 1, 2001;
19(7):
2033 - 2040.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Omura-Minamisawa, M. B. Diccianni, A. Batova, R. C. Chang, L. J. Bridgeman, J. Yu, J. Pullen, W. P. Bowman, and A. L. Yu
Universal Inactivation of Both p16 and p15 but not Downstream Components Is an Essential Event in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia
Clin. Cancer Res.,
April 1, 2000;
6(4):
1219 - 1228.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
I. H. N. Wong, M. H. L. Ng, D. P. Huang, and J. C. K. Lee
Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications
Blood,
March 15, 2000;
95(6):
1942 - 1949.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. W. Maloney, L. McGavran, L. F. Odom, and S. P. Hunger
Acquisition of p16INK4A and p15INK4B Gene Abnormalities Between Initial Diagnosis and Relapse in Children With Acute Lymphoblastic Leukemia
Blood,
April 1, 1999;
93(7):
2380 - 2385.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Villuendas, M. Sanchez-Beato, J. C. Martinez, A. I. Saez, B. Martinez-Delgado, J. F. Garcia, M. S. Mateo, L. Sanchez-Verde, J. Benitez, P. Martinez, et al.
Loss of p16/INK4A Protein Expression in Non-Hodgkin's Lymphomas Is a Frequent Finding Associated with Tumor Progression
Am. J. Pathol.,
September 1, 1998;
153(3):
887 - 897.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pinyol, F. Cobo, S. Bea, P. Jares, I. Nayach, P. L. Fernandez, E. Montserrat, A. Cardesa, and E. Campo
p16INK4a Gene Inactivation by Deletions, Mutations, and Hypermethylation Is Associated With Transformed and Aggressive Variants of Non-Hodgkin's Lymphomas
Blood,
April 15, 1998;
91(8):
2977 - 2984.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. M. Uckun, M. G. Sensel, L. Sun, P. G. Steinherz, M. E. Trigg, N. A. Heerema, H. N. Sather, G. H. Reaman, and P. S. Gaynon
Biology and Treatment of Childhood T-Lineage Acute Lymphoblastic Leukemia
Blood,
February 1, 1998;
91(3):
735 - 746.
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-T. Kong, K. Ida, H. Ichikawa, K. Shimizu, M. Ohki, N. Maseki, Y. Kaneko, M. Sako, Y. Kobayashi, A. Tojou, et al.
Consistent Detection of TLS/FUS-ERG Chimeric Transcripts in Acute Myeloid Leukemia With t(16; 21)(p11; q22) and Identification of a Novel Transcript
Blood,
August 1, 1997;
90(3):
1192 - 1199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. Matherly, J. W. Taub, S. C. Wong, P. M. Simpson, R. Ekizian, S. Buck, M. Williamson, M. Amylon, J. Pullen, B. Camitta, et al.
Increased Frequency of Expression of Elevated Dihydrofolate Reductase in T-Cell Versus B-Precursor Acute Lymphoblastic Leukemia in Children
Blood,
July 15, 1997;
90(2):
578 - 589.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. R. Kees, P. R. Burton, C. Lu, and D. L. Baker
Homozygous Deletion of the p16/MTS1 Gene in Pediatric Acute Lymphoblastic Leukemia Is Associated With Unfavorable Clinical Outcome
Blood,
June 1, 1997;
89(11):
4161 - 4166.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Ausserlechner, P. Obexer, G. J. Wiegers, B. L. Hartmann, S. Geley, and R. Kofler
The Cell Cycle Inhibitor p16INK4A Sensitizes Lymphoblastic Leukemia Cells to Apoptosis by Physiologic Glucocorticoid Levels
J. Biol. Chem.,
March 30, 2001;
276(14):
10984 - 10989.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
